Delivery Order SPE2DB22D3501-SPE2DB25FXK79
- Not listed
- The Defense Logistics Agency awarded a $36,669.75 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Ontruzant 420 mg vials. This is a firm fixed price, competitively awarded contract with performance scheduled to be completed by December 11, 2025, at the vendor's location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $2,310.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ontruzant 150 mg vials, with an ultimate completion date of September 12, 2025. This non-set-aside delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $5,748.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ontruzant 420 mg vials, with an ultimate completion date of August 22, 2025. The contract, issued on August 21, 2025, is a non-set-aside award reflecting open competition. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, serving as the prime contractor with no subcontractors identified. This...
- The Defense Logistics Agency awarded a $35.3K delivery order to AmerisourceBergen Drug Corp for the supply of Ontruzant 420 mg vials, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and designates AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is a child contract action issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $6,647.56 to AmerisourceBergen Drug Corp for the supply of Ontruzant 420 mg vials. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on August 4, 2025, with a final delivery date of August 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Ontruzant 150 mg vials valued at $10,937.50 on September 23, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by September 24, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Ontruzant 150 mg vials, a biosimilar oncology medication, with a ceiling value of $2,305.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 23, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award utilized no set-aside designation, reflecting open competition for this medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ontruzant 150 mg vials, with a ceiling value of $1,449.63. The contract is firm fixed price with an ultimate completion date of November 6, 2025, and was awarded on November 5, 2025 with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Ontruzant 150 mg vials with a ceiling value of $9,459.31. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for ultimate completion by September 30, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,179.53 to AmerisourceBergen Drug Corp for the supply of Ontruzant 150 mg vials, with an ultimate completion date of November 28, 2025. This non-competitive, firm fixed-price delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. The product will be delivered to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXK79Delivery Order
The Defense Logistics Agency awarded a $15,445.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ontruzant 420 mg vials, with completion scheduled for September 22, 2025. This competitive award, which included no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger Indefinite Delivery Contract (IDC) vehicle. This delivery order is issued under AmerisourceBergen's existing $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Ontruzant order fulfills pharmaceutical supply needs within the DLA's broader military medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.4k | 9/19/25 |